nodes	percent_of_prediction	percent_of_DWPC	metapath
Bisoprolol—CYP2D6—Temsirolimus—kidney cancer	0.105	0.169	CbGbCtD
Bisoprolol—CYP3A4—Everolimus—kidney cancer	0.099	0.159	CbGbCtD
Bisoprolol—CYP3A4—Temsirolimus—kidney cancer	0.0669	0.108	CbGbCtD
Bisoprolol—CYP2D6—Pazopanib—kidney cancer	0.0553	0.0889	CbGbCtD
Bisoprolol—CYP2D6—Erlotinib—kidney cancer	0.0394	0.0635	CbGbCtD
Bisoprolol—CYP3A4—Pazopanib—kidney cancer	0.0351	0.0566	CbGbCtD
Bisoprolol—CYP2D6—Sorafenib—kidney cancer	0.0321	0.0516	CbGbCtD
Bisoprolol—CYP2D6—Vinblastine—kidney cancer	0.0317	0.051	CbGbCtD
Bisoprolol—CYP3A4—Erlotinib—kidney cancer	0.0251	0.0404	CbGbCtD
Bisoprolol—CYP3A4—Paclitaxel—kidney cancer	0.023	0.0369	CbGbCtD
Bisoprolol—CYP3A4—Sorafenib—kidney cancer	0.0204	0.0328	CbGbCtD
Bisoprolol—CYP3A4—Vinblastine—kidney cancer	0.0201	0.0324	CbGbCtD
Bisoprolol—CYP3A4—Vincristine—kidney cancer	0.0198	0.0319	CbGbCtD
Bisoprolol—CYP2D6—Doxorubicin—kidney cancer	0.0195	0.0313	CbGbCtD
Bisoprolol—CYP3A4—Sunitinib—kidney cancer	0.0165	0.0266	CbGbCtD
Bisoprolol—CYP3A4—Doxorubicin—kidney cancer	0.0124	0.0199	CbGbCtD
Bisoprolol—Chlorphenesin—BCHE—kidney cancer	0.00129	0.338	CrCbGaD
Bisoprolol—Chlorphenesin—PTGS2—kidney cancer	0.000592	0.156	CrCbGaD
Bisoprolol—Atenolol—ABCB1—kidney cancer	0.000504	0.132	CrCbGaD
Bisoprolol—Acebutolol—ABCB1—kidney cancer	0.000465	0.122	CrCbGaD
Bisoprolol—Metoprolol—ABCB1—kidney cancer	0.000392	0.103	CrCbGaD
Bisoprolol—Propranolol—CYP1A1—kidney cancer	0.000373	0.0978	CrCbGaD
Bisoprolol—Propranolol—ABCB1—kidney cancer	0.000198	0.052	CrCbGaD
Bisoprolol—Osteoarthritis—Doxorubicin—kidney cancer	0.000191	0.00051	CcSEcCtD
Bisoprolol—Paraesthesia—Gemcitabine—kidney cancer	0.000191	0.000509	CcSEcCtD
Bisoprolol—Flushing—Capecitabine—kidney cancer	0.000191	0.000508	CcSEcCtD
Bisoprolol—Cardiac disorder—Capecitabine—kidney cancer	0.000191	0.000508	CcSEcCtD
Bisoprolol—Cough—Paclitaxel—kidney cancer	0.00019	0.000507	CcSEcCtD
Bisoprolol—Asthenia—Sunitinib—kidney cancer	0.00019	0.000506	CcSEcCtD
Bisoprolol—Dyspnoea—Gemcitabine—kidney cancer	0.000189	0.000505	CcSEcCtD
Bisoprolol—Nausea—Vinblastine—kidney cancer	0.000189	0.000504	CcSEcCtD
Bisoprolol—Somnolence—Gemcitabine—kidney cancer	0.000189	0.000504	CcSEcCtD
Bisoprolol—Affect lability—Doxorubicin—kidney cancer	0.000188	0.000502	CcSEcCtD
Bisoprolol—Nausea—Everolimus—kidney cancer	0.000188	0.000502	CcSEcCtD
Bisoprolol—Diarrhoea—Sorafenib—kidney cancer	0.000188	0.000502	CcSEcCtD
Bisoprolol—Pruritus—Sunitinib—kidney cancer	0.000187	0.000499	CcSEcCtD
Bisoprolol—Angiopathy—Capecitabine—kidney cancer	0.000186	0.000497	CcSEcCtD
Bisoprolol—Chest pain—Paclitaxel—kidney cancer	0.000185	0.000495	CcSEcCtD
Bisoprolol—Arthralgia—Paclitaxel—kidney cancer	0.000185	0.000495	CcSEcCtD
Bisoprolol—Myalgia—Paclitaxel—kidney cancer	0.000185	0.000495	CcSEcCtD
Bisoprolol—Mediastinal disorder—Capecitabine—kidney cancer	0.000185	0.000494	CcSEcCtD
Bisoprolol—Anxiety—Paclitaxel—kidney cancer	0.000185	0.000493	CcSEcCtD
Bisoprolol—Hypersensitivity—Dactinomycin—kidney cancer	0.000185	0.000492	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000184	0.000491	CcSEcCtD
Bisoprolol—Arrhythmia—Capecitabine—kidney cancer	0.000183	0.000489	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000183	0.000489	CcSEcCtD
Bisoprolol—Discomfort—Paclitaxel—kidney cancer	0.000183	0.000489	CcSEcCtD
Bisoprolol—Fatigue—Gemcitabine—kidney cancer	0.000183	0.000488	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Vincristine—kidney cancer	0.000183	0.000488	CcSEcCtD
Bisoprolol—Cardiac arrest—Doxorubicin—kidney cancer	0.000182	0.000485	CcSEcCtD
Bisoprolol—Dizziness—Sorafenib—kidney cancer	0.000182	0.000485	CcSEcCtD
Bisoprolol—Pain—Gemcitabine—kidney cancer	0.000182	0.000484	CcSEcCtD
Bisoprolol—Constipation—Gemcitabine—kidney cancer	0.000182	0.000484	CcSEcCtD
Bisoprolol—Nausea—Erlotinib—kidney cancer	0.000182	0.000484	CcSEcCtD
Bisoprolol—Alopecia—Capecitabine—kidney cancer	0.000181	0.000484	CcSEcCtD
Bisoprolol—Dry mouth—Paclitaxel—kidney cancer	0.000181	0.000484	CcSEcCtD
Bisoprolol—Mood swings—Doxorubicin—kidney cancer	0.000181	0.000483	CcSEcCtD
Bisoprolol—Diarrhoea—Sunitinib—kidney cancer	0.000181	0.000483	CcSEcCtD
Bisoprolol—Mental disorder—Capecitabine—kidney cancer	0.00018	0.00048	CcSEcCtD
Bisoprolol—Asthenia—Dactinomycin—kidney cancer	0.00018	0.000479	CcSEcCtD
Bisoprolol—Confusional state—Paclitaxel—kidney cancer	0.000179	0.000478	CcSEcCtD
Bisoprolol—Erythema—Capecitabine—kidney cancer	0.000179	0.000477	CcSEcCtD
Bisoprolol—Oedema—Paclitaxel—kidney cancer	0.000178	0.000474	CcSEcCtD
Bisoprolol—Abdominal pain—Vincristine—kidney cancer	0.000177	0.000472	CcSEcCtD
Bisoprolol—Body temperature increased—Vincristine—kidney cancer	0.000177	0.000472	CcSEcCtD
Bisoprolol—Infection—Paclitaxel—kidney cancer	0.000177	0.000471	CcSEcCtD
Bisoprolol—Dysgeusia—Capecitabine—kidney cancer	0.000175	0.000467	CcSEcCtD
Bisoprolol—Dizziness—Sunitinib—kidney cancer	0.000175	0.000467	CcSEcCtD
Bisoprolol—Feeling abnormal—Gemcitabine—kidney cancer	0.000175	0.000467	CcSEcCtD
Bisoprolol—Shock—Paclitaxel—kidney cancer	0.000175	0.000467	CcSEcCtD
Bisoprolol—Vomiting—Sorafenib—kidney cancer	0.000175	0.000466	CcSEcCtD
Bisoprolol—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000175	0.000466	CcSEcCtD
Bisoprolol—Abdominal pain upper—Doxorubicin—kidney cancer	0.000175	0.000466	CcSEcCtD
Bisoprolol—Nervous system disorder—Paclitaxel—kidney cancer	0.000174	0.000465	CcSEcCtD
Bisoprolol—Thrombocytopenia—Paclitaxel—kidney cancer	0.000174	0.000464	CcSEcCtD
Bisoprolol—Tachycardia—Paclitaxel—kidney cancer	0.000174	0.000463	CcSEcCtD
Bisoprolol—Rash—Sorafenib—kidney cancer	0.000173	0.000463	CcSEcCtD
Bisoprolol—Dermatitis—Sorafenib—kidney cancer	0.000173	0.000462	CcSEcCtD
Bisoprolol—Back pain—Capecitabine—kidney cancer	0.000173	0.000461	CcSEcCtD
Bisoprolol—Breast disorder—Doxorubicin—kidney cancer	0.000173	0.000461	CcSEcCtD
Bisoprolol—Skin disorder—Paclitaxel—kidney cancer	0.000173	0.000461	CcSEcCtD
Bisoprolol—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	0.000172	0.00046	CcSEcCtD
Bisoprolol—Headache—Sorafenib—kidney cancer	0.000172	0.00046	CcSEcCtD
Bisoprolol—Muscle spasms—Capecitabine—kidney cancer	0.000172	0.000458	CcSEcCtD
Bisoprolol—Hyperhidrosis—Paclitaxel—kidney cancer	0.000172	0.000458	CcSEcCtD
Bisoprolol—Diarrhoea—Dactinomycin—kidney cancer	0.000171	0.000457	CcSEcCtD
Bisoprolol—Gastritis—Doxorubicin—kidney cancer	0.000169	0.000452	CcSEcCtD
Bisoprolol—Muscular weakness—Doxorubicin—kidney cancer	0.000169	0.00045	CcSEcCtD
Bisoprolol—Vomiting—Sunitinib—kidney cancer	0.000168	0.000449	CcSEcCtD
Bisoprolol—Body temperature increased—Gemcitabine—kidney cancer	0.000168	0.000448	CcSEcCtD
Bisoprolol—Tremor—Capecitabine—kidney cancer	0.000167	0.000447	CcSEcCtD
Bisoprolol—Rash—Sunitinib—kidney cancer	0.000167	0.000445	CcSEcCtD
Bisoprolol—Dermatitis—Sunitinib—kidney cancer	0.000167	0.000445	CcSEcCtD
Bisoprolol—Hypotension—Paclitaxel—kidney cancer	0.000166	0.000443	CcSEcCtD
Bisoprolol—Ill-defined disorder—Capecitabine—kidney cancer	0.000166	0.000442	CcSEcCtD
Bisoprolol—Headache—Sunitinib—kidney cancer	0.000166	0.000442	CcSEcCtD
Bisoprolol—Asthma—Doxorubicin—kidney cancer	0.000165	0.000441	CcSEcCtD
Bisoprolol—Hypersensitivity—Vincristine—kidney cancer	0.000165	0.00044	CcSEcCtD
Bisoprolol—Nausea—Sorafenib—kidney cancer	0.000163	0.000436	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000162	0.000432	CcSEcCtD
Bisoprolol—Malaise—Capecitabine—kidney cancer	0.000161	0.00043	CcSEcCtD
Bisoprolol—Insomnia—Paclitaxel—kidney cancer	0.000161	0.000429	CcSEcCtD
Bisoprolol—Vertigo—Capecitabine—kidney cancer	0.000161	0.000428	CcSEcCtD
Bisoprolol—Asthenia—Vincristine—kidney cancer	0.000161	0.000428	CcSEcCtD
Bisoprolol—Syncope—Capecitabine—kidney cancer	0.00016	0.000428	CcSEcCtD
Bisoprolol—Paraesthesia—Paclitaxel—kidney cancer	0.00016	0.000426	CcSEcCtD
Bisoprolol—Vomiting—Dactinomycin—kidney cancer	0.000159	0.000425	CcSEcCtD
Bisoprolol—Bronchitis—Doxorubicin—kidney cancer	0.000159	0.000424	CcSEcCtD
Bisoprolol—Dyspnoea—Paclitaxel—kidney cancer	0.000158	0.000423	CcSEcCtD
Bisoprolol—Somnolence—Paclitaxel—kidney cancer	0.000158	0.000422	CcSEcCtD
Bisoprolol—Palpitations—Capecitabine—kidney cancer	0.000158	0.000421	CcSEcCtD
Bisoprolol—Rash—Dactinomycin—kidney cancer	0.000158	0.000421	CcSEcCtD
Bisoprolol—Nausea—Sunitinib—kidney cancer	0.000157	0.000419	CcSEcCtD
Bisoprolol—Loss of consciousness—Capecitabine—kidney cancer	0.000157	0.000419	CcSEcCtD
Bisoprolol—Dyspepsia—Paclitaxel—kidney cancer	0.000156	0.000417	CcSEcCtD
Bisoprolol—Cough—Capecitabine—kidney cancer	0.000156	0.000416	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000153	0.000409	CcSEcCtD
Bisoprolol—Fatigue—Paclitaxel—kidney cancer	0.000153	0.000409	CcSEcCtD
Bisoprolol—Diarrhoea—Vincristine—kidney cancer	0.000153	0.000409	CcSEcCtD
Bisoprolol—Asthenia—Gemcitabine—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Chest pain—Capecitabine—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Arthralgia—Capecitabine—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Myalgia—Capecitabine—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Constipation—Paclitaxel—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Pain—Paclitaxel—kidney cancer	0.000152	0.000406	CcSEcCtD
Bisoprolol—Anxiety—Capecitabine—kidney cancer	0.000152	0.000405	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000151	0.000403	CcSEcCtD
Bisoprolol—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000151	0.000403	CcSEcCtD
Bisoprolol—Weight increased—Doxorubicin—kidney cancer	0.000151	0.000401	CcSEcCtD
Bisoprolol—Discomfort—Capecitabine—kidney cancer	0.00015	0.000401	CcSEcCtD
Bisoprolol—Pruritus—Gemcitabine—kidney cancer	0.00015	0.000401	CcSEcCtD
Bisoprolol—Dry mouth—Capecitabine—kidney cancer	0.000149	0.000397	CcSEcCtD
Bisoprolol—Nausea—Dactinomycin—kidney cancer	0.000149	0.000397	CcSEcCtD
Bisoprolol—Pneumonia—Doxorubicin—kidney cancer	0.000148	0.000396	CcSEcCtD
Bisoprolol—Dizziness—Vincristine—kidney cancer	0.000148	0.000395	CcSEcCtD
Bisoprolol—Drowsiness—Doxorubicin—kidney cancer	0.000147	0.000393	CcSEcCtD
Bisoprolol—Confusional state—Capecitabine—kidney cancer	0.000147	0.000392	CcSEcCtD
Bisoprolol—Feeling abnormal—Paclitaxel—kidney cancer	0.000146	0.000391	CcSEcCtD
Bisoprolol—Oedema—Capecitabine—kidney cancer	0.000146	0.000389	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000145	0.000388	CcSEcCtD
Bisoprolol—Diarrhoea—Gemcitabine—kidney cancer	0.000145	0.000388	CcSEcCtD
Bisoprolol—Infection—Capecitabine—kidney cancer	0.000145	0.000387	CcSEcCtD
Bisoprolol—Shock—Capecitabine—kidney cancer	0.000144	0.000383	CcSEcCtD
Bisoprolol—Conjunctivitis—Doxorubicin—kidney cancer	0.000143	0.000382	CcSEcCtD
Bisoprolol—Urinary tract infection—Doxorubicin—kidney cancer	0.000143	0.000382	CcSEcCtD
Bisoprolol—Nervous system disorder—Capecitabine—kidney cancer	0.000143	0.000382	CcSEcCtD
Bisoprolol—Thrombocytopenia—Capecitabine—kidney cancer	0.000143	0.000381	CcSEcCtD
Bisoprolol—Tachycardia—Capecitabine—kidney cancer	0.000142	0.00038	CcSEcCtD
Bisoprolol—Vomiting—Vincristine—kidney cancer	0.000142	0.00038	CcSEcCtD
Bisoprolol—Skin disorder—Capecitabine—kidney cancer	0.000142	0.000378	CcSEcCtD
Bisoprolol—Sweating—Doxorubicin—kidney cancer	0.000141	0.000377	CcSEcCtD
Bisoprolol—Urticaria—Paclitaxel—kidney cancer	0.000141	0.000377	CcSEcCtD
Bisoprolol—Rash—Vincristine—kidney cancer	0.000141	0.000376	CcSEcCtD
Bisoprolol—Hyperhidrosis—Capecitabine—kidney cancer	0.000141	0.000376	CcSEcCtD
Bisoprolol—Dermatitis—Vincristine—kidney cancer	0.000141	0.000376	CcSEcCtD
Bisoprolol—Abdominal pain—Paclitaxel—kidney cancer	0.000141	0.000375	CcSEcCtD
Bisoprolol—Body temperature increased—Paclitaxel—kidney cancer	0.000141	0.000375	CcSEcCtD
Bisoprolol—Headache—Vincristine—kidney cancer	0.00014	0.000374	CcSEcCtD
Bisoprolol—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000139	0.000372	CcSEcCtD
Bisoprolol—Sinusitis—Doxorubicin—kidney cancer	0.000138	0.000369	CcSEcCtD
Bisoprolol—Agranulocytosis—Doxorubicin—kidney cancer	0.000138	0.000367	CcSEcCtD
Bisoprolol—Hypotension—Capecitabine—kidney cancer	0.000136	0.000364	CcSEcCtD
Bisoprolol—Vomiting—Gemcitabine—kidney cancer	0.000135	0.00036	CcSEcCtD
Bisoprolol—Bradycardia—Doxorubicin—kidney cancer	0.000135	0.000359	CcSEcCtD
Bisoprolol—Rash—Gemcitabine—kidney cancer	0.000134	0.000357	CcSEcCtD
Bisoprolol—Dermatitis—Gemcitabine—kidney cancer	0.000134	0.000357	CcSEcCtD
Bisoprolol—Headache—Gemcitabine—kidney cancer	0.000133	0.000355	CcSEcCtD
Bisoprolol—Nausea—Vincristine—kidney cancer	0.000133	0.000355	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000133	0.000355	CcSEcCtD
Bisoprolol—Rhinitis—Doxorubicin—kidney cancer	0.000133	0.000354	CcSEcCtD
Bisoprolol—Hepatitis—Doxorubicin—kidney cancer	0.000132	0.000353	CcSEcCtD
Bisoprolol—Insomnia—Capecitabine—kidney cancer	0.000132	0.000352	CcSEcCtD
Bisoprolol—Hypoaesthesia—Doxorubicin—kidney cancer	0.000132	0.000351	CcSEcCtD
Bisoprolol—Pharyngitis—Doxorubicin—kidney cancer	0.000131	0.00035	CcSEcCtD
Bisoprolol—Paraesthesia—Capecitabine—kidney cancer	0.000131	0.000349	CcSEcCtD
Bisoprolol—Hypersensitivity—Paclitaxel—kidney cancer	0.000131	0.000349	CcSEcCtD
Bisoprolol—Oedema peripheral—Doxorubicin—kidney cancer	0.00013	0.000348	CcSEcCtD
Bisoprolol—Connective tissue disorder—Doxorubicin—kidney cancer	0.00013	0.000347	CcSEcCtD
Bisoprolol—Dyspnoea—Capecitabine—kidney cancer	0.00013	0.000347	CcSEcCtD
Bisoprolol—Dyspepsia—Capecitabine—kidney cancer	0.000128	0.000343	CcSEcCtD
Bisoprolol—Visual impairment—Doxorubicin—kidney cancer	0.000128	0.00034	CcSEcCtD
Bisoprolol—Asthenia—Paclitaxel—kidney cancer	0.000128	0.00034	CcSEcCtD
Bisoprolol—Nausea—Gemcitabine—kidney cancer	0.000126	0.000336	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000126	0.000336	CcSEcCtD
Bisoprolol—Fatigue—Capecitabine—kidney cancer	0.000126	0.000336	CcSEcCtD
Bisoprolol—Pruritus—Paclitaxel—kidney cancer	0.000126	0.000336	CcSEcCtD
Bisoprolol—Pain—Capecitabine—kidney cancer	0.000125	0.000333	CcSEcCtD
Bisoprolol—Constipation—Capecitabine—kidney cancer	0.000125	0.000333	CcSEcCtD
Bisoprolol—Eye disorder—Doxorubicin—kidney cancer	0.000124	0.00033	CcSEcCtD
Bisoprolol—Tinnitus—Doxorubicin—kidney cancer	0.000123	0.000329	CcSEcCtD
Bisoprolol—Cardiac disorder—Doxorubicin—kidney cancer	0.000123	0.000328	CcSEcCtD
Bisoprolol—Flushing—Doxorubicin—kidney cancer	0.000123	0.000328	CcSEcCtD
Bisoprolol—Diarrhoea—Paclitaxel—kidney cancer	0.000122	0.000324	CcSEcCtD
Bisoprolol—Feeling abnormal—Capecitabine—kidney cancer	0.00012	0.000321	CcSEcCtD
Bisoprolol—Angiopathy—Doxorubicin—kidney cancer	0.00012	0.00032	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000119	0.000318	CcSEcCtD
Bisoprolol—Mediastinal disorder—Doxorubicin—kidney cancer	0.000119	0.000318	CcSEcCtD
Bisoprolol—Arrhythmia—Doxorubicin—kidney cancer	0.000118	0.000315	CcSEcCtD
Bisoprolol—Dizziness—Paclitaxel—kidney cancer	0.000118	0.000314	CcSEcCtD
Bisoprolol—Alopecia—Doxorubicin—kidney cancer	0.000117	0.000312	CcSEcCtD
Bisoprolol—Mental disorder—Doxorubicin—kidney cancer	0.000116	0.000309	CcSEcCtD
Bisoprolol—Urticaria—Capecitabine—kidney cancer	0.000116	0.000309	CcSEcCtD
Bisoprolol—Body temperature increased—Capecitabine—kidney cancer	0.000115	0.000308	CcSEcCtD
Bisoprolol—Abdominal pain—Capecitabine—kidney cancer	0.000115	0.000308	CcSEcCtD
Bisoprolol—Erythema—Doxorubicin—kidney cancer	0.000115	0.000307	CcSEcCtD
Bisoprolol—Vomiting—Paclitaxel—kidney cancer	0.000113	0.000302	CcSEcCtD
Bisoprolol—Dysgeusia—Doxorubicin—kidney cancer	0.000113	0.000301	CcSEcCtD
Bisoprolol—Rash—Paclitaxel—kidney cancer	0.000112	0.000299	CcSEcCtD
Bisoprolol—Dermatitis—Paclitaxel—kidney cancer	0.000112	0.000299	CcSEcCtD
Bisoprolol—Back pain—Doxorubicin—kidney cancer	0.000111	0.000297	CcSEcCtD
Bisoprolol—Headache—Paclitaxel—kidney cancer	0.000111	0.000297	CcSEcCtD
Bisoprolol—Muscle spasms—Doxorubicin—kidney cancer	0.000111	0.000296	CcSEcCtD
Bisoprolol—Hypersensitivity—Capecitabine—kidney cancer	0.000107	0.000287	CcSEcCtD
Bisoprolol—Ill-defined disorder—Doxorubicin—kidney cancer	0.000107	0.000285	CcSEcCtD
Bisoprolol—Agitation—Doxorubicin—kidney cancer	0.000106	0.000282	CcSEcCtD
Bisoprolol—Nausea—Paclitaxel—kidney cancer	0.000106	0.000282	CcSEcCtD
Bisoprolol—Asthenia—Capecitabine—kidney cancer	0.000105	0.000279	CcSEcCtD
Bisoprolol—Malaise—Doxorubicin—kidney cancer	0.000104	0.000277	CcSEcCtD
Bisoprolol—Vertigo—Doxorubicin—kidney cancer	0.000104	0.000276	CcSEcCtD
Bisoprolol—Syncope—Doxorubicin—kidney cancer	0.000103	0.000276	CcSEcCtD
Bisoprolol—Pruritus—Capecitabine—kidney cancer	0.000103	0.000275	CcSEcCtD
Bisoprolol—Palpitations—Doxorubicin—kidney cancer	0.000102	0.000272	CcSEcCtD
Bisoprolol—Loss of consciousness—Doxorubicin—kidney cancer	0.000101	0.00027	CcSEcCtD
Bisoprolol—Cough—Doxorubicin—kidney cancer	0.000101	0.000268	CcSEcCtD
Bisoprolol—Diarrhoea—Capecitabine—kidney cancer	9.98e-05	0.000266	CcSEcCtD
Bisoprolol—Myalgia—Doxorubicin—kidney cancer	9.81e-05	0.000262	CcSEcCtD
Bisoprolol—Chest pain—Doxorubicin—kidney cancer	9.81e-05	0.000262	CcSEcCtD
Bisoprolol—Arthralgia—Doxorubicin—kidney cancer	9.81e-05	0.000262	CcSEcCtD
Bisoprolol—Anxiety—Doxorubicin—kidney cancer	9.78e-05	0.000261	CcSEcCtD
Bisoprolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	9.74e-05	0.00026	CcSEcCtD
Bisoprolol—Discomfort—Doxorubicin—kidney cancer	9.69e-05	0.000259	CcSEcCtD
Bisoprolol—Dizziness—Capecitabine—kidney cancer	9.65e-05	0.000257	CcSEcCtD
Bisoprolol—Dry mouth—Doxorubicin—kidney cancer	9.59e-05	0.000256	CcSEcCtD
Bisoprolol—Confusional state—Doxorubicin—kidney cancer	9.48e-05	0.000253	CcSEcCtD
Bisoprolol—Oedema—Doxorubicin—kidney cancer	9.4e-05	0.000251	CcSEcCtD
Bisoprolol—Infection—Doxorubicin—kidney cancer	9.34e-05	0.000249	CcSEcCtD
Bisoprolol—Vomiting—Capecitabine—kidney cancer	9.28e-05	0.000247	CcSEcCtD
Bisoprolol—Shock—Doxorubicin—kidney cancer	9.25e-05	0.000247	CcSEcCtD
Bisoprolol—Nervous system disorder—Doxorubicin—kidney cancer	9.22e-05	0.000246	CcSEcCtD
Bisoprolol—Thrombocytopenia—Doxorubicin—kidney cancer	9.21e-05	0.000246	CcSEcCtD
Bisoprolol—Rash—Capecitabine—kidney cancer	9.2e-05	0.000245	CcSEcCtD
Bisoprolol—Dermatitis—Capecitabine—kidney cancer	9.19e-05	0.000245	CcSEcCtD
Bisoprolol—Tachycardia—Doxorubicin—kidney cancer	9.18e-05	0.000245	CcSEcCtD
Bisoprolol—Headache—Capecitabine—kidney cancer	9.14e-05	0.000244	CcSEcCtD
Bisoprolol—Skin disorder—Doxorubicin—kidney cancer	9.13e-05	0.000244	CcSEcCtD
Bisoprolol—Hyperhidrosis—Doxorubicin—kidney cancer	9.09e-05	0.000243	CcSEcCtD
Bisoprolol—Hypotension—Doxorubicin—kidney cancer	8.79e-05	0.000234	CcSEcCtD
Bisoprolol—Nausea—Capecitabine—kidney cancer	8.67e-05	0.000231	CcSEcCtD
Bisoprolol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.57e-05	0.000229	CcSEcCtD
Bisoprolol—Insomnia—Doxorubicin—kidney cancer	8.51e-05	0.000227	CcSEcCtD
Bisoprolol—Paraesthesia—Doxorubicin—kidney cancer	8.44e-05	0.000225	CcSEcCtD
Bisoprolol—Dyspnoea—Doxorubicin—kidney cancer	8.38e-05	0.000224	CcSEcCtD
Bisoprolol—Somnolence—Doxorubicin—kidney cancer	8.36e-05	0.000223	CcSEcCtD
Bisoprolol—Dyspepsia—Doxorubicin—kidney cancer	8.28e-05	0.000221	CcSEcCtD
Bisoprolol—Gastrointestinal disorder—Doxorubicin—kidney cancer	8.12e-05	0.000217	CcSEcCtD
Bisoprolol—Fatigue—Doxorubicin—kidney cancer	8.11e-05	0.000216	CcSEcCtD
Bisoprolol—Constipation—Doxorubicin—kidney cancer	8.04e-05	0.000215	CcSEcCtD
Bisoprolol—Pain—Doxorubicin—kidney cancer	8.04e-05	0.000215	CcSEcCtD
Bisoprolol—Feeling abnormal—Doxorubicin—kidney cancer	7.75e-05	0.000207	CcSEcCtD
Bisoprolol—Gastrointestinal pain—Doxorubicin—kidney cancer	7.69e-05	0.000205	CcSEcCtD
Bisoprolol—Urticaria—Doxorubicin—kidney cancer	7.47e-05	0.000199	CcSEcCtD
Bisoprolol—Abdominal pain—Doxorubicin—kidney cancer	7.43e-05	0.000198	CcSEcCtD
Bisoprolol—Body temperature increased—Doxorubicin—kidney cancer	7.43e-05	0.000198	CcSEcCtD
Bisoprolol—Hypersensitivity—Doxorubicin—kidney cancer	6.93e-05	0.000185	CcSEcCtD
Bisoprolol—Asthenia—Doxorubicin—kidney cancer	6.75e-05	0.00018	CcSEcCtD
Bisoprolol—Pruritus—Doxorubicin—kidney cancer	6.65e-05	0.000177	CcSEcCtD
Bisoprolol—Diarrhoea—Doxorubicin—kidney cancer	6.43e-05	0.000172	CcSEcCtD
Bisoprolol—Dizziness—Doxorubicin—kidney cancer	6.22e-05	0.000166	CcSEcCtD
Bisoprolol—Vomiting—Doxorubicin—kidney cancer	5.98e-05	0.000159	CcSEcCtD
Bisoprolol—Rash—Doxorubicin—kidney cancer	5.93e-05	0.000158	CcSEcCtD
Bisoprolol—Dermatitis—Doxorubicin—kidney cancer	5.92e-05	0.000158	CcSEcCtD
Bisoprolol—Headache—Doxorubicin—kidney cancer	5.89e-05	0.000157	CcSEcCtD
Bisoprolol—Nausea—Doxorubicin—kidney cancer	5.59e-05	0.000149	CcSEcCtD
